✦ LIBER ✦

Cardiovascular morbidity and mortality in the losartan intervention for end point reduction in hypertension study (LIFE): a randomised trial against atenolol

✍ Scribed by B. Dahlof; B.R. Devereux; S.E. Kjeldsen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular morbidity and mortality i

✍ Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beever 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 124 KB

Cardiovascular morbidity and mortality i

✍ L.H. Lindholm; H. Ibsen; B. Dahof 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Cardiovascular morbidity and mortality i

✍ Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; U 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 110 KB

Cardiovascular morbidity and mortality i

✍ Kristian Wachtell; Björn Hornestam; Mika Lehto; David J. Slotwiner; Eva Gerdts; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 212 KB

The Effect of Losartan Versus Atenolol o

✍ Eigil Fossum; Andreas Moan; Sverre E. Kjeldsen; Richard B. Devereux; Stevo Juliu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Effects of losartan on cardiovascular mo

✍ S.E. Kjeldsen; B. Dahlor; R.B. Devereux 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 33 KB